Atlas Trials

Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes

Clinical trial NCT07452913 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07452913
Sponsor
Bahria University
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2026-01-01
Primary completion
2026-03-30
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.